Clinical News and Research

RSS

Potassium Isotope Ratios: A Potential Biomarker for Early Alzheimer's Disease Diagnosis

Potassium isotope ratios in serum show promise as biomarkers for Alzheimer's disease, revealing significant differences between patients and healthy controls.

16 Sep 2024

CHIEF Model Transforms Cancer Evaluation with Enhanced Generalizability Across Diverse Histopathology Samples

The CHIEF model revolutionizes cancer diagnosis, leveraging histopathological imaging to predict tumor origins and survival outcomes with exceptional accuracy.

16 Sep 2024

New Initiative Targets High-Risk Genes to Understand Neurodevelopmental and Psychiatric Disorders

Neurodevelopmental and psychiatric disorders (NPD) including schizophrenia, bipolar disorder, autism, and depression are detrimental to individuals, their families and society as a whole, and in many cases still lack effective treatments.

13 Sep 2024

CRISPR and Antibodies Offer New Hope for Improving CAR-T Cell Therapy Outcomes

Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients.

13 Sep 2024

Monoclonal Antibody SC27 Shows Broad Effectiveness Against SARS-CoV-2 Variants

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

10 Sep 2024

Common Skin Fungus Identified as a Potential Factor in Tumor Growth

A common skin fungus, Malassezia globosa may invade deep tissues through the skin or by other means, then cause tumor growth, according to a new study.

6 Sep 2024

AMLo Biosciences Receives UKCA Mark for Groundbreaking Melanoma Biomarker Test

AMLo Biosciences Ltd (Newcastle upon Tyne, UK) announces the successful receipt of the UKCA mark for AMBLor. AMBLor is a groundbreaking histopathological biomarker test for the personal identification of early-stage melanomas at low risk of progression, post staging diagnosis.

6 Sep 2024

HudsonAlpha Scientists Receive NIH Grant to Enhance Genetic Testing for Rare Diseases

As genetic sequencing technology becomes more accessible and efficient, researchers have made significant strides in understanding the genetic underpinnings of various diseases. This knowledge has led to a surge in clinical applications of genetic testing, offering hope and improved outcomes for individuals affected by many genetic diseases and disorders.

5 Sep 2024

Innovative Computational Tool Analyzes Gut Microbiome for Early Health Insights

A team of Mayo Clinic researchers has developed a unique computational tool that analyzes the gut microbiome, a complex ecosystem of trillions of bacteria, fungi, viruses, and other microorganisms within the digestive system, to provide insights about general well-being.

5 Sep 2024

Researchers Uncover Hundreds of New Potential Cancer Driver Genes

Researchers at the Centre for Genomic Regulation (CRG) have discovered hundreds of potential new cancer driver genes.

4 Sep 2024

Bacteria's Ability to Sense Chemical Changes Across Their Cell Bodies Uncovered

Scientists at the University of Sheffield have discovered a new sensory capability in bacteria that could transform treatments for bacterial infections.

4 Sep 2024

New Advances in DEL Technology Facilitate Synthesis of Large, Complex Molecules

These days, remarkable new medical treatments are all the rage. One such treatment is personalized cancer therapy, which uses antibodies or immune cells that have been altered.

4 Sep 2024

Beta Cells Alone Can Maintain Glycemic Balance Without Other Pancreatic Cells

Our glycemic balance is based on the ability of the pancreatic beta cells to detect glucose and secrete insulin to maintain our blood sugar levels.

4 Sep 2024

Melbourne Researchers Achieve Breakthrough in Creating Human-Like Blood Stem Cells

Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body.

3 Sep 2024

Microbiotica Secures Approvals to Begin Clinical Studies in EU and UK for New Microbiome Medicines

Microbiotica, a biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), is pleased to announce that it has received regulatory approvals to initiate clinical studies for its first two programmes in advanced melanoma (MELODY-1) and ulcerative colitis (COMPOSER-1) in selected EU countries and the UK. Both studies are due to start shortly, with initial data readouts expected by the end of 2025.

30 Aug 2024

European Commission Approves Erdafitinib for Advanced Urothelial Carcinoma

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved BALVERSA®▼(erdafitinib) as a once-daily oral monotherapy for the treatment of adult patients with unresectable or metastatic urothelial carcinoma (mUC), harbouring susceptible fibroblast growth factor receptor 3 (FGFR3) genetic alterations who have previously received at least one line of therapy containing a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor in the unresectable or metastatic treatment setting.

30 Aug 2024

RYBREVANT Receives EC Nod for Advanced Lung Cancer Treatment

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved a Type II extension of indication for RYBREVANT®▼ (amivantamab) in combination with chemotherapy (carboplatin and pemetrexed), for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 19 deletions (ex19del) or Exon 21 L858R substitution (L858R) mutations, after failure of prior therapy including an EGFR tyrosine kinase inhibitor (TKI).

30 Aug 2024

Clinical News and Research

Potassium Isotope Ratios: A Potential Biomarker for Early Alzheimer's Disease Diagnosis

CHIEF Model Transforms Cancer Evaluation with Enhanced Generalizability Across Diverse Histopathology Samples

New Initiative Targets High-Risk Genes to Understand Neurodevelopmental and Psychiatric Disorders

CRISPR and Antibodies Offer New Hope for Improving CAR-T Cell Therapy Outcomes

Monoclonal Antibody SC27 Shows Broad Effectiveness Against SARS-CoV-2 Variants

Common Skin Fungus Identified as a Potential Factor in Tumor Growth

AMLo Biosciences Receives UKCA Mark for Groundbreaking Melanoma Biomarker Test

HudsonAlpha Scientists Receive NIH Grant to Enhance Genetic Testing for Rare Diseases

Innovative Computational Tool Analyzes Gut Microbiome for Early Health Insights

Researchers Uncover Hundreds of New Potential Cancer Driver Genes

Bacteria's Ability to Sense Chemical Changes Across Their Cell Bodies Uncovered

New Advances in DEL Technology Facilitate Synthesis of Large, Complex Molecules

Beta Cells Alone Can Maintain Glycemic Balance Without Other Pancreatic Cells

Melbourne Researchers Achieve Breakthrough in Creating Human-Like Blood Stem Cells

Microbiotica Secures Approvals to Begin Clinical Studies in EU and UK for New Microbiome Medicines

European Commission Approves Erdafitinib for Advanced Urothelial Carcinoma

RYBREVANT Receives EC Nod for Advanced Lung Cancer Treatment

Pan-Pathogen Deep Sequencing: A New Strategy in Combating Nosocomial Antimicrobial Resistant Bacterial Infections

A Landmark Study Reveals the Widespread Existence of DNA i-Motifs

Bacterial Protein Utilizes DNA for Target Recognition and Plasmid Elimination

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics